The Healthcare Conversation That’s Long Overdue: Dr. James Frizzell Examines Cannabis Addiction

As legalization spreads and social attitudes shift, more Americans have access to cannabis than ever before. 

According to Dr. James Frizzell, this surge brings with it a heightened need for awareness about both the potential benefits and risks associated with cannabis. What was once a fringe topic in clinical settings has moved squarely into the mainstream, and healthcare systems are now being called upon to address cannabis use with the same rigor as other substances. Yet persistent stigma, inconsistent screening, and limited provider training remain major obstacles that slow this progress. 

Recognizing the warning signs of problematic use is crucial, as is fostering open, nonjudgmental communication between patients and providers. The challenge is not simply medical but cultural, requiring a willingness to talk about cannabis honestly and without assumption. By improving education, updating clinical protocols, and supporting ongoing research, healthcare can better respond to the realities of cannabis use and help individuals make informed decisions about their health. Dr. Frizzell emphasizes that this is a conversation the medical community can no longer afford to delay.

Shifting Patterns in Cannabis Use Across the U.S.

Cannabis consumption in the United States has seen a rise in recent years. As of 2024, nearly a quarter of American adults report using cannabis, with daily or near-daily use rising sharply. This increase is especially notable among younger adults and in regions where legalization has expanded access. The growth has not been gradual or evenly distributed, but rather concentrated in states that have moved toward recreational legalization, where the practical and legal barriers to purchase have largely disappeared.

In some communities, cannabis use now surpasses daily alcohol consumption, reflecting changing social attitudes and perceived risks. For many people, cannabis has shed its association with rebellion or counterculture and become a routine part of daily life, used for relaxation, sleep, pain management, or stress relief. These trends highlight a growing need to understand how consumption patterns may impact public health and healthcare practices. 

The rapid normalization of cannabis is influencing not just individual behaviors but also broader societal norms, shaping how families, workplaces, and communities think about a substance that was illegal almost everywhere just a generation ago. This shift also raises questions that the healthcare system is only beginning to answer. 

As products become more potent and more varied, ranging from traditional flower to concentrates and edibles, the relationship between consumption and health outcomes grows more complex. Understanding who is using cannabis, how often, and in what form has become an essential part of preventive care.

Recognizing Cannabis Use Disorder (CUD)

Cannabis Use Disorder is identified by a pattern of problematic use that leads to distress or difficulties in daily life. Symptoms may include an inability to cut down despite wanting to, persistent cravings, or using cannabis even when it interferes with work or relationships. Other indicators can involve needing larger amounts to achieve the same effect, spending significant time obtaining or recovering from use, and continuing despite clear negative consequences. 

Research shows that about three in ten people who use cannabis may develop CUD at some point, making it a more common condition than many realize. This statistic challenges the widespread belief that cannabis carries no real risk of dependence. 

While the substance may be less likely to produce the dramatic physical withdrawal associated with some other drugs, the psychological and behavioral patterns of dependence are very real for a meaningful portion of users. This underscores the importance of recognizing warning signs and understanding that CUD is a diagnosable medical issue, not simply a matter of personal choice. Framing the condition this way matters because it shifts the conversation away from blame and toward treatment. When patients and providers alike understand that dependence can develop without any moral failing, the door opens to earlier intervention and more honest discussion.

Health Consequences Linked to Cannabis Addiction

Long-term cannabis use can have a lasting impact on cognitive functions such as memory, learning, and decision-making. These effects can be subtle at first, accumulating over time in ways that users themselves may not immediately notice. Some users experience mood changes or increased anxiety, which can complicate daily responsibilities or relationships, sometimes creating a cycle in which cannabis is used to manage the very symptoms it may be worsening. 

In certain populations, regular use has been associated with an elevated risk of developing psychotic disorders, especially among those with a personal or family history of mental health issues. This connection is among the more serious concerns in the clinical literature and underscores the importance of personalized risk assessment. A substance that poses minimal apparent risk to one individual may carry significant danger for another, depending on age, genetics, and underlying vulnerabilities. 

These health effects highlight the need for open conversations about cannabis risks and support for those who may be struggling. Ongoing studies continue to examine the nuances of these risks across different age groups and genetic backgrounds. The picture that emerges is not one of simple harm or simple safety, but of a substance whose effects vary widely from person to person. That variability is precisely why individualized, informed medical guidance is so valuable.

How Healthcare Systems Address Cannabis Use

Healthcare systems are adapting slowly to the landscape of cannabis use. Many clinics incorporate basic screening questions about substance use during routine visits, but detailed assessments for cannabis use disorder remain inconsistent. A patient might be asked whether they use cannabis without any follow-up about frequency, quantity, or impact, leaving providers with an incomplete picture and patients without meaningful feedback. 

Within organizations such as the Veterans Health Administration, some progress has been made in integrating mental health support and substance use interventions, though these efforts are not always widespread. These institutional models offer useful examples of how cannabis care can be folded into broader treatment, but they have not yet become standard across the healthcare system as a whole. 

In general practice, providers may rely on brief counseling or referrals, yet many patients with problematic cannabis use remain undetected or untreated. This gap can lead to missed opportunities for early intervention and support for those at risk. When problematic use goes unidentified, it can progress quietly until it begins to cause more serious harm, at which point intervention becomes more difficult and the consequences more entrenched.

Barriers to Open Healthcare Discussions on Cannabis

Open conversations about cannabis in healthcare settings are often hindered by lingering stigma and misconceptions. Many patients worry about being judged or facing repercussions if they disclose their use, leading to underreporting during medical appointments. This hesitation can be especially pronounced among patients who have experienced judgment in the past or who fear that honesty might affect their care or their relationships with providers. On the provider side, a lack of clear clinical guidelines and limited training creates uncertainty about how to approach the topic. 

Without established protocols, even well-intentioned clinicians may avoid the subject or handle it inconsistently, unsure of what questions to ask or how to interpret the answers. 

This communication gap means that opportunities to identify and address cannabis-related problems are frequently missed. Addressing these barriers will require a cultural shift within healthcare that values transparency and patient-centered care. The goal is to create an environment in which patients feel safe being honest, and providers feel equipped to respond. That kind of trust cannot be built overnight, but it begins with treating cannabis use as a legitimate health topic rather than a source of embarrassment or suspicion.

Pathways to Improving Engagement

Enhancing how healthcare addresses cannabis use starts with routine screening and more robust education for providers. When screening becomes a standard part of care rather than an occasional afterthought, problematic use is more likely to be caught early. Equally important is giving providers the knowledge and confidence to discuss cannabis openly, drawing on current research rather than outdated assumptions. 

Normalizing conversations about cannabis, much like discussions around alcohol or tobacco, can foster trust and encourage patients to be forthcoming. When patients understand that disclosure will be met with support rather than judgment, they are far more likely to share accurate information, which in turn allows for better care. 

By updating clinical protocols and investing in research, healthcare systems can better support individuals at risk of cannabis-related harm and guide policy changes that prioritize patient well-being. Dr. Frizzell notes that this is not about discouraging cannabis use outright, but about ensuring that those who do use it can do so with full awareness of the risks and with access to help if they need it. The conversation is long overdue, and the path forward depends on meeting it with honesty, education, and care.